Madorra study

Research status

Completed

Overview of Study

Vaginal dryness (secondary to vulvovaginal atrophy) affects over half of post-menopausal women, who may experience everyday discomfort, increased rates of urinary tract and yeast infections, and pain with sexual intercourse. It is also often experienced by breast cancer survivors, due to treatments that cause oestrogen levels to drop. Currently, the most effective treatment for vaginal dryness is topical hormone therapy; however the safety of this is of concern for some women, such as breast cancer survivors.

Family Planning NSW is currently partnering in a clinical trial evaluating an investigational, non-hormonal medical device designed to treat vaginal dryness in post-menopausal women, including breast cancer survivors. This device can be used discreetly in the privacy of the user’s home and does not involve any hormones or medications.

If you qualify and choose to join the study, you will be seen by a clinician at Family Planning NSW in our Ashfield clinic and will receive all study-related care at no cost. The study is conducted over a 12 month study period. You will be asked to visit the Ashfield clinic 6 times to discuss your experience and symptoms, and you will be reimbursed for their travel costs to attend these visits.

If you are a postmenopausal women and/or cancer survivor with vaginal dryness due to vaginal atrophy, you may be eligible to participate. Please contact us for more information.

This study has been reviewed and approved by the Family Planning NSW Ethics Committee.

Partners:

Madorra Pty Ltd

Contact Details

If you think this may be of interest to you or you would like more information about the study, please contact Prue Kidman (T): 02 8752 4355 or (E) researchcentre@fpnsw.org.au